Voyager Therapeutics (VYGR) Treasury Shares (2014 - 2026)
Voyager Therapeutics (VYGR) posted Treasury Shares of $2.1 million for Q1 2026, down 8.2% sequentially from $2.3 million in Q4 2025, and down 25.99% YoY from $2.8 million in Q1 2025.
Voyager Therapeutics (VYGR) Treasury Shares (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Treasury Shares for 13 years, with the latest figure at $2.1 million in Q1 2026.
- Quarterly Treasury Shares fell 25.99% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 25.99% YoY) and the FY2025 annual result came in at $2.3 million, up 39.21% from the prior year.
- Treasury Shares retreated to $2.1 million in Q1 2026 per VYGR's latest filing, from $2.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $2.8 million in Q1 2025 and troughed at $941275.0 in Q3 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares slumped 31.7% in 2022, then surged 65.72% in 2025.
- Over 5 years, Treasury Shares stood at $1.1 million in 2022, then climbed by 23.22% to $1.4 million in 2023, then gained by 20.35% to $1.6 million in 2024, then soared by 39.21% to $2.3 million in 2025, then slipped by 8.2% to $2.1 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.1 million, $2.3 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Mn |
| Jun 30, 2026 | 1.92 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.72 Mn |